Meeting
2022 ASCO Annual Meeting
Co-occurrence of germline pathogenic variants in Chinese patients with solid tumors.
Authors
Yan Zhang
The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
Yan Zhang , Tiantian Han , Didi Guo , Ningning Luo , Guanghua Lu , Fanfeng Bu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10579)
DOI
10.1200/JCO.2022.40.16_suppl.10579
Abstract #
10579
Poster Bd #
454
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Double jeopardy? A closer look at cancer histories of individuals with multiple germline pathogenic variants.
First Author: Carolyn Horton
Poster
2022 ASCO Annual Meeting
Retrospective analysis of non-BRCA gene pathogenicity variation in Chinese patients with ovarian cancer.
First Author: Li yuan Guo
Poster
2019 ASCO Annual Meeting
Prevalence of pathogenic germline variants in DNA repair by race, age, and ethnicity in men with prostate cancer.
First Author: Alexandria Mara
Poster
2019 ASCO Annual Meeting
Tumor sequencing with germline genetic testing: Identification of patients with hereditary cancer and precision treatment eligibility.
First Author: Scott T. Michalski